Table 1 Baseline characteristics of participants
From: Serum zinc concentration and history of isCGM contact dermatitis in type 1 diabetes
N (Men/Women) | 55 (23/32) |
|---|---|
Age, years | 57.9 ± 17.6 |
Age at onset of diabetes, years | 41.0 ± 18.9 |
Duration of diabetes, years | 18.3 ± 14.5 |
Height, cm | 160.1 ± 9.3 |
Body weight, kg | 59.5 ± 11.1 |
BMI, kg/m2 | 23.2 ± 3.9 |
HbA1c, % | 7.8 ± 2.1 |
Fasting serum C-peptide, ng/dL | 0.31 ± 0.52 |
TC, mg/dl | 191.2 ± 40.6 |
LDL-C, mg/dl | 98.9 ± 35.6 |
TG, mg/dl | 90.0 (66.0–131.0) |
HDL-C, mg/dl | 66.4 ± 20.0 |
TP, mg/dl | 6.8 ± 0.8 |
Alb, mg/dl | 4.0 ± 0.6 |
Estimated GFR, ml/min/1.73 m2 | 79.7 (65.9–96.1) |
Urinary albumin-to-creatinine ratio, mg Alb/g Cre | 11.0 (7.0–31.0) |
Diabetic nephropathy stage (1/2/3/4/5) | 41/10/2/2/0 |
Diabetic retinopathy stage | |
(NDR/SDR/PPDR/PDR) | 43/5/2/5 |
Zn, μg/dL | 76.2 ± 14.2 |
Serum zinc classification | |
(Normal/Subclinical deficiency/Deficiency) | 22/27/6 |
History of contact dermatitis due to isCGM (Yes/No) | 23/32 |